IGF1R and neoplasm: Among these, enhanced effects on apoptosis enhancement, cell cycle arrest, and reduced tumor load in the 5TMM model in vivo were achieved by combining a novel HDAC inhibitor, LBH589 (panobinostat), with the IGF-1R inhibitor PPP (78).